Skip to main content
Premium Trial:

Request an Annual Quote

Pall Corporation, Eksigent Techonologies


Pall Corporation introduced three new protein purification kits this week designed to remove albumin and immunoglobulin G from human and animal-derived serum and plasma samples.

The kits are being marketed as two Enchant Life Sciences Kits for IgG and one Enchant Life Sciences Kit for Albumin Depletion.

Since albumin and IgG make up approximately 80 percent of the total protein content in human serum, “there is a critical need for diagnostic tools to rapidly deplete these unwanted abundant proteins and unmask the low-abundance, low-molecular-weight protein biomarkers that offer researchers hope for developing new therapeutics,” company officials said in a statement last week.

Eksigent Techonologies has launched microfluidic systems called NanoLC-1D and NanoLC-2D that allow for the microscale pumping that is often necessary when working in proteomics with small volumes of protein samples. The pumping systems interface with mass spectrometers, allowing for a potential of zero sample loss.

Other microscale equipment produced by the company include the ExpressLC-100 and ExpressLC-800 systems for high-throughput analytical HPLC and the EKPump Drug Delivery Systems.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.